Milestone Pharmaceuticals to Present at Upcoming Investor Conferences
Webcasts for applicable Milestone Pharmaceuticals presentations will be available on the company’s website for about 90 days after the events.
Rhea-AI Summary
Milestone Pharmaceuticals (MIST)/b) will participate in three upcoming healthcare investor conferences in September 2026, featuring fireside chats and 1x1 meetings.Management presents at the Wells Fargo 21st Annual Healthcare Conference in Boston on September 8 at 1:30 pm ET, and at the H.C. Wainwright 28th Annual Global Investment Conference in New York on September 15 at 10:30 am ET. Milestone will also hold 1x1 meetings at the Cantor Global Healthcare Conference in New York on September 10. Webcasts for applicable presentations will be accessible for about 90 days via the company’s website.
Positive
- None.
Negative
- None.
News Market Reaction – MIST
In the Sep 2 session, MIST gained 3.51%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MONTREAL and CHARLOTTE, N.C., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that management will present at, and participate in, the following upcoming investor conferences.
| Conference Details | |
| Wells Fargo 21st Annual Healthcare Conference | |
| Format: | Fireside chat and 1x1s |
| Presentation Date: | September 8, 2026 |
| Time: | 1:30 pm ET |
| Location: | Boston, MA |
| Webcast link: | HERE |
| Cantor Global Healthcare Conference, New York | |
| Format: | 1x1s |
| Participation Date: | September 10, 2026 |
| Location: | New York, NY |
| H.C. Wainwright 28th Annual Global Investment Conference | |
| Format: | Fireside chat and 1x1s |
| Presentation Date: | September 15, 2026 |
| Time: | 10:30 am ET |
| Location: | New York, NY |
| Webcast link: | HERE |
To request a 1x1 meeting, please contact your representative at the relevant bank.
Webcasts of the presentations will be available for approximately 90 days following each event on the “News & Events” section of Milestone's website www.milestonepharma.com.
About Milestone Pharmaceuticals
Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is an emerging commercial-stage biopharmaceutical company advancing innovative cardiovascular medicines to benefit people living with certain heart conditions. Milestone’s lead product is CARDAMYST® (etripamil) nasal spray, a novel calcium channel blocker, which is FDA-approved for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. Etripamil is also in Phase 3 development for the control of symptomatic episodic attacks associated with AFib-RVR. https://milestonepharma.com/
Contact:
Investor Relations
Kevin Gardner, kgardner@lifesciadvisors.com
Media Relations
Rebecca Novak, rnovak@milestonepharma.com
